Ryan P. O'Connor

I'll research this attorney's professional background before drafting.

Let me disambiguate the firm history in the case list.

Found a key disambiguation issue. Let me verify the Lowenstein Sandler connection and EcoFactor counsel.

Attorney Summary — Ryan P. O'Connor

Specialty / focus. The most reliably sourced figure is Ryan Patrick O'Connor, a principal at Fish & Richardson in San Diego. His litigation practice spans pharmaceuticals (Hatch-Waxman/ANDA), biotechnology, medical devices, and computer hardware/software, with additional experience in specialty chemicals, fiber-optics coatings, internet advertising, and e-commerce technologies. His technical background is chemistry- and life-sciences-heavy: a B.S. in chemical engineering and B.A. in biochemistry from the University of Colorado Boulder, plus prior industry work as a biochemist (antibiotics research at Replidyne), a regulatory consultant to pharma/biotech/device companies, and an engineer at Kodak and Valspar.

Side preference. He works both sides rather than specializing as an NPE/PAE prosecutor or an operating-company defender. His reported docket includes patentee-side representations (Gilead, GSK, Allergan, Corning, ASUS as plaintiff) and defense-side representations for accused infringers (Amazon, Zappos, Netflix, Microsoft, Nationwide, Volcano, NuVasive, and more recently Apple). The tracked list's 2-plaintiff / 1-defendant split is too small a sample to support any firm characterization, and two of the three entries are questionable (see note below).

Firm context and notable matters. He has been with Fish & Richardson's Southern California office, described as principal since around 2015 (Martindale lists him as partner; Best Lawyers has recognized him in Litigation–Patent since 2023). Reported matters include Gilead Sciences v. AbbVie (Harvoni HCV litigation, D. Del.); GSK v. Teva and GSK v. Glenmark (Coreg, D. Del.); Allergan v. Sandoz (Combigan ANDA); Corning v. DSM Desotech (fiber-optic coatings); Warsaw Orthopedic v. NuVasive (spinal implants, with parallel reexaminations); and St. Jude Medical v. Volcano (client-favorable settlement). In ITC matters he was counsel for ASUS in IBM (337-TA-628), described as a trial win at the initial determination stage. More recent appearances in public filings include counsel for Apple in Neonode Smartphone v. Apple (N.D. Cal.) and Omnitracs v. Platform Science (S.D. Cal.).

PTAB / IPR. His firm bio states he handles U.S. post-grant proceedings alongside district court and ITC work, and public filings confirm active participation — e.g., a 2024 Sotera-style stipulation letter he signed as Apple's counsel in IPR2024-00983 (Resonant Systems/RevelHMI v. Apple, U.S. Pat. No. 11,152,882), and parallel inter partes reexaminations in Function Media v. Google. He is not, from available records, a high-volume PTAB petitioner in his own name; he appears as part of larger Fish teams.

Bar / education. J.D. and LL.M. (Intellectual Property), Franklin Pierce Law Center / University of New Hampshire School of Law, 2007; admitted in California (2007), Ohio (2006), and registered before the USPTO. Note that the Federal Circuit admission (2013) and some firm-tenure dates come from a lower-reliability secondary source and should be confirmed before use.

Caveats on the tracked data. Two entries in the structured list appear to involve different attorneys sharing this name and should not be attributed to the Fish & Richardson litigator:

• Altera Law Group — the Ryan O'Connor of counsel there is a patent agent, not a litigator: Ph.D. and B.S. in chemical engineering (Minnesota, Notre Dame), USPTO Reg. No. 56,693, co-founder of O'Connor & Company (2006), focused on patent preparation/prosecution in chemicals, materials, energy, and biotech. This profile does not match the Fish principal's education or practice.
• AG18, LLC v. DraftKings — publicly filed PTAB and Federal Circuit records show AG18's counsel of record were Setter Roche Smith & Shellenberger and later Perkins Coie, with DraftKings represented by Baker Botts. I found no Lowenstein Sandler or Ryan P. O'Connor appearance in those filings, so the "local counsel, Lowenstein Sandler" entry is unverified and likely misattributed. (For context, that dispute produced PTAB final written decisions invalidating the asserted claims and two 2026 nonprecedential Federal Circuit affirmances — but on the record I found, not with O'Connor as counsel.)

I'd recommend confirming the Lowenstein Sandler and Altera entries against the docket before relying on them; absent that, they should probably be dropped from his profile.